KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to 26.43%.

  • Amgen's EBIT Margin rose 23600.0% to 26.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.11%, marking a year-over-year increase of 49900.0%. This contributed to the annual value of 21.71% for FY2024, which is 63000.0% down from last year.
  • Latest data reveals that Amgen reported EBIT Margin of 26.43% as of Q3 2025, which was up 23600.0% from 28.94% recorded in Q2 2025.
  • In the past 5 years, Amgen's EBIT Margin ranged from a high of 40.08% in Q1 2022 and a low of 12.69% during Q2 2021
  • For the 5-year period, Amgen's EBIT Margin averaged around 28.09%, with its median value being 29.28% (2023).
  • In the last 5 years, Amgen's EBIT Margin tumbled by -247400bps in 2021 and then surged by 203100bps in 2022.
  • Quarter analysis of 5 years shows Amgen's EBIT Margin stood at 33.65% in 2021, then fell by -3bps to 32.61% in 2022, then plummeted by -52bps to 15.51% in 2023, then skyrocketed by 64bps to 25.43% in 2024, then grew by 4bps to 26.43% in 2025.
  • Its last three reported values are 26.43% in Q3 2025, 28.94% for Q2 2025, and 14.46% during Q1 2025.